Cleared Traditional

K201644 - QardioCore (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K201644 · Qardio, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2021
Decision
256d
Days
Class 2
Risk

K201644 is an FDA 510(k) clearance for the QardioCore. Classified as Recorder, Magnetic Tape, Medical (product code DSH), Class II - Special Controls.

Submitted by Qardio, Inc. (San Fransciso, US). The FDA issued a Cleared decision on February 28, 2021 after a review of 256 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Qardio, Inc. devices

Submission Details

510(k) Number K201644 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 17, 2020
Decision Date February 28, 2021
Days to Decision 256 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
131d slower than avg
Panel avg: 125d · This submission: 256d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DSH Recorder, Magnetic Tape, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSH Recorder, Magnetic Tape, Medical

All 193
Devices cleared under the same product code (DSH) and FDA review panel - the closest regulatory comparables to K201644.
Rhythm Master ECG Patch (HM-15BB-AX, HM-15BW-AX, HM-15BW-DX)
K252389 · Smwmed, Inc. · Apr 2026
VitaloJAK Clinic (Model 7100)
K253293 · Vitalograph , Ltd. · Dec 2025
Zio® monitor (DFG0001)
K243650 · iRhythm Technologies, Inc. · Aug 2025
AeviceMD
K243603 · Aevice Health Pte. , Ltd. · May 2025
AT-Patch (ATP-C130/ATP-C70)
K242583 · Atsens Co., Ltd. · May 2025
HiCardi+ H100
K232670 · MEZOO Co., Ltd. · Sep 2024